|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 5/0783 | |
| C07K 16/28 | |||
| C07K 14/725 | |||
| A61K 38/17 | |||
| A61K 35/17 | |||
| A61K 39/395 | |||
| A61P 35/00 |
| (11) | Number of the document | 2970372 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14770151.0 |
| Date of filing the European patent application | 2014-03-14 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/027039 |
| Date | 2014-03-14 |
| (87) | Number | WO 2014/152177 |
| Date | 2014-09-25 |
| (30) | Number | Date | Country code |
| 201361794294 P | 2013-03-15 | US |
| (72) |
ABBOT, Stewart, US
LI, Tianjian, US
LIANG, Bitao, US
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | MODIFIED T LYMPHOCYTES |
| MODIFIED T LYMPHOCYTES |